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Abstract
Background: Independence from all optical aids, and freedom from unwanted symptoms, following cataract and
lens surgery remains the ultimate goal of both patient and surgeon. The development of trifocal IOL technology
provides an ever-increasing range of options. The purpose of our study is to understand the predictability, safety
and efficacy of a new trifocal intraocular lens (IOL) following cataract or refractive lens exchange (RLE) surgery.
Methods: This was a retrospective consecutive case series of patients undergoing cataract extraction or RLE followed
by implantation of the Alcon IQ Panoptix IOL. Pre and postoperative refractive and visual parameters were recorded
and evaluated. As the cohort followed a normal distribution, standard parametric tests were used. Paired t-test was
used to compare the difference between target and postoperative refractive errors. The incidence of intraoperative and
postoperative complications was also reported.
Results: The IOL was implanted in 66 eyes of 33 patients. Mean postoperative spherical equivalent (SE) refraction was
-0.08 ± 0.25 dioptres (D). This was not significantly different from the target refraction (p = 0.841). Sixty-five percent of
patients were within ± 0.25 D of the target SE refraction with 100% within ± 0.50 D of intended correction. Mean
postoperative uncorrected distance visual acuity (UDVA) was 0.01 ± 0.10 LogMAR. All patients achieved an unaided
distance acuity of 20/40 or better postoperatively. Binocularly, 100% saw 0.20 LogMAR or better at near without
correction and 88.9% achieved this level for uncorrected intermediate visual acuity. No intraoperative complications
were noted. Five patients complained of moderate haloes in the early postoperative period.
Conclusion: The AcrySof IQ Panoptix IOL provides functional uncorrected visual acuity at distance, intermediate and
near positions. Our results remain equivalent with existing trifocal IOL outcomes and provide surgeons with a further
IOL alternative for the patient motivated to obtain true spectacle independence. Surgeons should consider
individual reading and working requirements when counselling patients preoperatively to optimise postoperative
patient satisfaction.
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Background
The use of presbyopia correcting intraocular lenses
(IOLs) has shown modest growth since their introduc-
tion in the 1980s with an approximate 2.4% share of the
current global IOL market [1]. High add powers domi-
nated early multifocal models providing excellent near
vision. A shift in functional vision requirements however
has more recently seen a move towards lower add powers
enabling good intermediate acuity (i.e. for use with desk-
top computers) and augmented distance vision [2, 3]. The
recent development of trifocal IOLs provides an expanded
range of unaided close vision allowing for further benefits
over multifocal IOL predecessors [4–9]. Most available tri-
focal models utilise a diffractive platform albeit with an
emphasis upon slightly different focal points for near and
intermediate activities (between 35 to 45 cm and 60 to
80 cm, respectively). These new options provide the oph-
thalmologist with an opportunity to customise the ap-
proach to individual patient requirements.
The Acrysof IQ Panoptix IOL (Alcon Surgical, Inc.)
represents the most recent addition to the presbyopia-
correcting trifocal IOL market. To our knowledge, we
provide the first significant case series of patients under-
going cataract or refractive lens extraction with implant-
ation of the Panoptix IOL describing the visual and
safety outcomes in a retrospective, multi-centre cohort.
Methods
A retrospective assessment of consecutive patients
undergoing implantation of the AcrySof IQ Panoptix
IOL (Alcon Labs, Ft Worth, TX, USA) at 3 separate cen-
tres with 5 doctors (ML, JR, LL, TR, UB) was performed.
The indication for surgery included both cataract re-
moval and refractive lens exchange (RLE). All patients
were motivated to obtain independence from optical aids
following surgery. Patients with significant concurrent
ocular disease that would contribute to poor postopera-
tive visual acuity were not considered for the use of the
multifocal IOL. Furthermore, the available version of the
Panoptix IOL was non-toric, this excluded patients that
would have benefited from a toric IOL. Previously, the
Panoptix IOL had been approved by the Australian
Therapeutic Goods Administration (TGA) regulations
agency and use of the IOL was thereby not considered
off-label. File notes confirmed that operating surgeons
discussed the following with each patient prior to sur-
gery: the risk of vision loss and or surgical complica-
tions, the possibility of continued need for optical aids
and the presence of optical phenomena such as haloes
or glare post-surgery. Surgical consent was obtained in
each case before proceeding.
The AcrySof IQ Panoptix IOL specifications and sur-
gery have been described elsewhere [9]. Briefly, the IOL
is a 1-piece aspheric hydrophobic IOL. The IOL has a
6 mm optical zone with a central 4.5 mm (15 diffractive
zones) and an outer refractive zone to deliver 3 focal
points from distance to intermediate and near ranges.
Light from the first focal point is diffracted to the dis-
tance focus. Optimal close reading distances are pro-
vided at 60 cm and 42 cm. The light efficiency of the
IOL has been measured at 88% for distance which re-
mains comparable to existing multifocal intraocular
lenses [10].
The surgery was performed in each case with topical
anaesthesia. A femtosecond laser (LenSx, Alcon Ft
Worth, TX, USA) was used to create the capsulorhexis
and provide phacofragmentation. Corneal incisions were
created manually through a 2.2 mm incision. The com-
pany provided “A” constant was used in conjunction
with either Holladay II or Barrett Universal II IOL calcu-
lation formulas as per surgeon preference (Holladay IOL
Consultant, Houston, TX, USA and www.apacrs.org/
barrett_universal2 respectively). Refractive targets
aimed for the minimum residual myopia. Postoperative
medication regimen varied slightly between clinics
however, each patient received a combination of anti-
biotic and anti-inflammatory drops titrated through
4 weeks following surgery.
Patients returned for follow up at 1 day, 1 week,
4 weeks and 2 months. The most recent follow up visit
details were recorded. Monocular and binocular uncor-
rected distance, intermediate (60 cm) and near (40 cm)
visual acuities were collected. Visual acuity was con-
verted from Snellen and Revised American Point-Type
to LogMAR for analysis. Near and intermediate reading
charts were limited to a minimum of N4 (Snellen
equivalent approximately 20/25). Intraoperative and
postoperative complications were recorded.
Data was collected in Microsoft Excel prior to analysis
of basic parameters. The cohort followed a normal dis-
tribution therefore, standard parametric tests were used.
The paired t-test was used to compare the difference
between target spherical equivalent (SE) refraction and
postoperative SE.
Results
Sixty-six eyes of 33 patients underwent cataract or clear
lens extraction and implantation of an AcrySof IQ
Panoptix IOL. Thirty-eight eyes underwent RLE (57.6%).
Preoperative demographics are listed in Table 1. The
mean length of follow up was 5.7 ± 1.7 weeks (range 4 to
9 weeks). The range of IOL powers used varied between
18.5 D and 27.5 D. The mean preoperative corneal cylin-
der was 0.50 ± 0.28 D (range 0 to 1.02 D).
Visual acuity
Mean preoperative corrected distance visual acuity
(CDVA) was 0.09 ± 0.20 LogMAR(approximately 20/25).
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Mean postoperative uncorrected distance visual acuity
(UDVA) was 0.01 ± 0.10 LogMAR (approximately 20/20).
78.8% of patients achieved 20/20 UDVA or better. All pa-
tients achieved an UDVA of 20/40 or better postopera-
tively (Fig. 1).
The mean uncorrected intermediate visual acuity
(UIVA) was 0.30 ± 0.14 LogMAR. Eighty-seven percent
(87.9%) of patients achieved 0.40 LogMAR or better at
60 cm monocularly (N8 or J6 equivalent). Fifty percent
(50%) of patients achieved 0.2 LogMAR or better (N6 or
J2 equivalent) near unaided monocularly with 88.9%
additionally achieving this level of vision binocularly at
60 cm at the final visit (Fig. 2). Sixty-three percent
(63.6%) of patients achieved 0.14 LogMAR equivalent or
better (N4 or J2) for monocular uncorrected near visual
acuity (UNVA). Mean LogMAR UNVA was 0.18 ± 0.10.
As expected, this increased significantly to 85.2%
when both eyes were used together (mean 0.11 ± 0.04
LogMAR) (Fig. 2).
Refraction
Mean postoperative SE refraction was -0.08 ± 0.25 D.
This was not significantly different from the target re-
fraction (absolute mean difference from target -0.01 ±
0.22 D, p = 0.854). Almost two-thirds (65.1%) of patients
were within ± 0.25 D of the target refraction with 100%
within ± 0.50 D of intended correction. Figure 3 shows
the attempted vs. achieved SE (see Additional file 1 for
individual vision and refractive outcomes).
At the final postoperative visit, 78.8% of patients
achieved UDVA of 0.0 LogMAR or better. Eyes that did
not achieve this level had a mean SE of -0.35 ± 0.20 D
and mean residual cylinder of -0.45 ± 0.28 D. Those pa-
tients achieving 0.0 LogMAR or better had a mean SE of
-0.01 ± 0.22 D and mean residual cylinder of -0.09 ± 0.15
D. The difference in SE and cylinder error between
groups was statistically significant (p = 0.000, 0.000).
Complications
No intraoperative complications were noted. Five patients
complained of moderate glare or haloes through the initial
postoperative period following the procedure. This how-
ever was not deemed sufficient to impair general activities
nor require explant. All patients reported the phenomena
diminishing by the subsequent postoperative visit (be-
tween 4 weeks to 3 months). There was no tendency to
favour either the RLE or cataract group (3 patients/2 pa-
tients, respectively). Three patients described having to
hold general text closer than prior to surgery, which ne-
cessitated minor adjustments to their work environment.
Each of these patients confirmed the unaided vision
remained more than adequate for their required tasks.
One eye (2.9%) in the RLE group lost 1 line of CDVA
at 2 weeks due to drop-related corneal epithelial toxicity
however, this resolved by the final visit. Additionally,
20.6% of RLE patients gained 1 line following surgery.
Two eyes (7.1%) of one cataract patient did not obtain
corrected distance vision (CDVA) of 0.00 LogMAR (20/
20) post-operatively. This patient was found to have mild
drusen following removal of the cataract that was not
Table 1 Preoperative characteristics
Mean (SD) Min Max
Sphere (D) 1.66 (1.21) −1.50 +4.00
Cylinder (D) −0.50 (0.39) −1.50 0.00
SE (D) 1.41 (1.21) −1.75 4.00
Mean keratometry (D) 43.12 (1.25) 40.81 45.39
Corneal Astigmatism (D) 0.46 (0.26) 0.00 1.17
Axial length (mm) 23.33 (0.82) 21.44 24.66
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apparent prior to surgery. The remaining 92.9% of
patients gained between 1 and 6 lines of CDVA.
Discussion
Presbyopia correcting IOLs represent a significant clin-
ical breakthrough for patients [11]. More recently, the
introduction of trifocal IOL models provide surgeons
with additional options when considering appropriate
IOL selection. Comparative literature highlights the ex-
tended reading range provided by the three separate
focal points of the trifocal IOLs compared to multifocal
IOLs, leading to greater optical independence for all
distances [9, 12, 13]. Conversely, the presence of two
out-of-focus images increases the likelihood of haloes
compared to a single out-of-focus image [14]. Optical
bench comparisons between trifocal and multifocal IOLs
confirm this albeit with some variation, attributed to
IOL design [2, 11, 15–18]. Practical outcomes however,
suggest that patient satisfaction remains high despite the
increased presence of optical phenomena [19, 20]. Discuss-
ing the presence of haloes following trifocal IOL implant-
ation is essential in any preoperative patient discussion.
Our study confirms the predictability and safety of the
Panoptix IOL. Our outcomes are consistent with other
non-toric trifocal studies. Kohnen previously published
the initial findings for the lens reporting the initial out-
comes of four patients with the Panoptix IOL. All pa-










































Fig. 2 Frequency of Postoperative UIVA and UNVA
Fig. 3 Attempted SE vs. Achieved SE
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albeit at 1 week follow up. Haloes and glare were present
but not considered significant [10]. Separately, Kohnen
et al. recently report a mean UDVA of 0.01 ± 0.11 Log-
MAR with the AtLisa trifocal IOL at 1 and 3 months
[21]. Cochener et al. report an UDVA of 0.08 ± 0.11 Log-
MAR at 3 months following implantation of the FineVi-
sion IOL [22]. The follow-up study in 2014 indicated
slightly improved results reporting a mean UDVA of
0.01 ± 0.06 LogMAR [5]. Sheppard et al. reported a
mean monocular UDVA of 0.19 ± 0.09 LogMAR in a
small sample at 2 months with the same IOL [23]. Law
et al. found a mean UDVA of 0.05 ± 0.07 LogMAR at
6 months with the AtLisa trifocal IOL [19]. Mojzis et al.
report a mean monocular UDVA of -0.03 ± 0.09 LogMAR
at 6 months also for the AtLisa IOL [24]. Our results ap-
pear broadly equivalent with these findings (0.01 ± 0.10
LogMAR) at a similar postoperative time period. Consid-
ering the oft-described process of adaptation, it would be
reasonably expected that the unaided vision in our cohort
may continue to improve with further follow-up.
The different focal points between models makes
direct comparisons of near and intermediate reading
values more difficult [9]. The variation in reading
tests and their respective limitations similarly impacts
comparative references. Considering our results at the
measured intermediate and near ranges however, the
Panoptix IOL again provides similar findings. Jonkers
et al. in a comparative study reported an UIVA and
UNVA of 0.32 ± 0.15 and 0.15 ± 0.13 LogMAR, re-
spectively, with the FineVision trifocal IOL [9]. In a
small study of 22 eyes, Attia et al. report a mean
UIVA and UNVA of 20/20.47 and 20/26.39 respect-
ively, also with the FineVision IOL [6]. Further, Moj-
zis et al. report equivalent results at the intermediate
range with the AtLisa trifocal 0.08 ± 0.10 LogMAR,
replicated by Cochener and co-authors in their group
with the same IOL model. UNVA in the latter reports
were 0.20 ± 0.12 and -0.03 ± 0.04 LogMAR, respect-
ively [5, 24]. Eighty-seven percent (87.9%) of our pa-
tients saw 0.20 LogMAR or greater at intermediate
whilst 100% achieved this level or better binocularly.
Patients who were found to have visual acuity worse
than 0.00 LogMAR for distance notably had higher
levels of postoperative refractive cylinder emphasizing
the importance of limiting residual astigmatism. The
use of arcuate incisions represents an option for sur-
geons, although it is expected a toric version of the
trifocal will be available in early 2017 to further assist
in minimizing overall postoperative refractive errors.
There were no intraoperative complications within
our cohort. Five patients reported moderate haloes ini-
tially following surgery. This is consistent with other
presbyopia correcting IOLs and with recent bench test-
ing outcomes [25, 26]. Carson et al. suggested that the
Panoptix Trifocal IOL showed equivalent or better per-
formance in image quality and resolution compared
with alternate trifocal IOLs. Importantly, all patients
noted improvement in symptoms over time likely indi-
cating the neuroadaptation process. Further, no patient
felt that the haloes impeded their routine activities,
suggesting that they were comfortable with the trade-
off between symptoms and optical independence. Sev-
eral patients noted that they had to make adjustments
to their standard reading distances. In each case, the
patient had slightly more residual myopia than ex-
pected, which may have brought forward the respective
focal points. This confirms the importance of both ac-
curate biometry calculations and preoperative
counselling.
The Alcon Panoptix IOL is based on the same
Acrysof 1-piece platform of the single focus IOL. This
may have potential advantages over existing models.
The stability of this platform has previously been re-
ported [27–29]. Our early refractive outcomes based
on the company provided “A” constant suggest that
stability and consistency of lens positioning is readily
achievable with the new model. In comparison, the
AtLisa trifocal IOL is based on a plate-haptic design,
which has previously correlated with additional move-
ment within the capsular bag post-surgery [27, 28].
As previously shown across several optical simula-
tions, tilt and decentration may have an impact upon
visual performance [29, 30]. This may be exacerbated
within presbyopia-correcting IOLs, which demand op-
timal positioning for maximum effective outcomes.
Visual outcomes with the AtLisa trifocal remain ex-
cellent however and this putative advantage over plate
haptic IOLs remains speculative [31]. The introduc-
tion of a toric version of the Panoptix model and fur-
ther testing may provide additional results to support
this hypothesis.
Conclusions
Our study represents the initial review of a new tri-
focal IOL. Overall, the IQ Panoptix IOL appears to
provide both safety and visual profiles similar to
current trifocal models without significant postopera-
tive visual symptoms. Further prospective, case–con-
trol studies incorporating additional quality of vision
and other subjective traits as well as reading mea-
sures may provide more appropriate comparisons with
alternate trifocal models [32]. Irrespective of these
studies, our results present a further IOL for surgeons
to consider in their preoperative assessment with
cataract and refractive lens patients who are seeking
full optical independence. Particular consideration of
patient reading and working requirements is required
to optimise the lens model choice.
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